Amyloid oligomer conformation in a group of natively folded proteins

PLoS ONE

Volumn 3, Issue 9, 2008, Pages

  Yoshiike, Yuji ^a   Minai, Ryoichi ^b   Matsuo, Yo ^b   Chen, Yun Ru ^c   Kimura, Tetsuya ^a   Takashima, Akihiko ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b RIKEN YOKOHAMA INSTITUTE   (Japan)

^c GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CHAPERONE; HEAT SHOCK PROTEIN 104; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; OLIGOMER; PROTEIN ANTIBODY; CHAPERONIN; EPITOPE; HSPB1 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; BETA SHEET; BINDING SITE; IMMUNOBLOTTING; MASS SPECTROMETRY; MOLECULAR PROBE; PHYSICAL CHEMISTRY; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; WESTERN BLOTTING; ANIMAL; CATTLE; CHEMISTRY; CONFORMATION; HUMAN; PROTEIN DENATURATION; PROTEIN SECONDARY STRUCTURE; STATISTICAL MODEL;

BACTERIA (MICROORGANISMS); BOVINAE;

AMYLOID; ANIMALS; BINDING SITES; CATTLE; EPITOPES; GROEL PROTEIN; HSP27 HEAT-SHOCK PROTEINS; HUMANS; MODELS, STATISTICAL; MOLECULAR CONFORMATION; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY;

EID: 52449103780     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003235     Document Type: Article

References (50)

1. Fandrich M, Fletcher MA, Dobson CM (2001) Amyloid fibrils from muscle myoglobin. Nature 410: 165-166.
2. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489.
3. Colby DW, Zhang Q, Wang S, Groth D, Legname G, et al. (2007) Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A 104: 20914-20919.
4. Dobson CM (2003) Protein folding and misfolding. Nature 426: 884-890.
5. Gidalevitz T, Ben-Zvi A, Ho KH, Brignull HR, Morimoto RI (2006) Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311: 1471-1474.
6. Hartl FU, Hayer-Hartl M (2002) Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295: 1852-1858.
7. LeVine H (1993) Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci 2: 404-410.
8. Muchowski PJ, Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6: 11-22.
9. Evans CG, Wisén S, Gestwicki JE (2006) Heat shock proteins 70 and 90 inhibit early stages of amyloid β-(1-42) aggregation in vitro. J Biol Chem 281: 33182-33191.
10. Wilhelmus MM, Boelens WC, Otte-Höller I, Kamps B, de Waal RM, et al. (2006) Small heat shock proteins inhibit amyloid-β protein aggregation and cerebrovascular amyloid-β protein toxicity. Brain Res 1089: 67-78.
11. Anfinsen CB (1973) Principles that govern the folding of protein chains. Science 181: 223-230.
12. Ehrnsperger M, Graber S, Gaestel M, Buchner J (1997) Binding of non-native protein to Hsp25 during heat shock creates a reservoir of folding intermediates for reactivation. EMBO J 16: 221-229.
13. Schwarzman AL, Gregori L, Vitek MP, Lyubski S, Strittmatter WJ, et al. (1994) Transthyretin sequesters amyloid-β protein and prevents amyloid formation. Proc Natl Acad Sci USA 91: 8368-8372.
14. Stein TD, Johnson JA (2002) Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J Neurosci 22: 7380-7388.
15. Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, et al. (1998) α2-macroglobulin is genetically associated with Alzheimer disease. Nat Genetics 19: 357-360.
16. Hughes SR, Khorkova O, Goyal S, Knaeblein J, Heroux J, et al. (1995) α2-macroglobulin associates with β-amyloid peptide and prevents fibril formation. Proc Natl Acad Sci USA 95: 3275-3280.
17. Du Y, Bales KR, Dodel RC, Liu X, Glinn MA, et al. (1998) α2-macroglobulin attenuates β-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J Neurochem 70: 1182-1188.
18. Reixach N, Deechongkit S, Jiang X, Kelly JW, Buxbaum JN (2004) Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc Natl Acad Sci USA 101: 2817-2822.
19. Blake CC, Oatley SJ (1977) Protein-DNA and protein-hormone interactions in prealbumin: a model of the thyroid hormone nuclear receptor? Nature 268: 115-120.
20. Jenner L, Husted L, Thirup S, Sottrup-Jensen L, Nyborg J (1998) Crystal structure of the receptor-binding domain of α2-macroglobulin. Structure 6: 595-604.
21. Choe S, Bennett MJ, Fujii G, Curmi PM, Kantardjieff KA, et al. (1992) The crystal structure of diphtheria toxin. Nature 357: 216-222.
22. Allured VS, Collier RJ, Carroll SF, McKay DB (1986) Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-angstrom resolution. Proc Natl Acad Sci USA 83: 1320-1324.
23. Kimura T, Takahashi S, Akiyama S, Uzawa T, Ishimori K, et al. (2002) Direct observation of the multistep helix formation of poly-L-glutamic acids. J Am Chem Soc 124: 11596-11597.
24. Ermolenko DN, Zherdev AV, Dzantiev BB (2004) Antibodies as specific chaperones. Biochemistry (Mosc) 69: 1233-1238.
25. Xu Q, Xie Z, Ding J, Lin SX, Xu G (2004) Monoclonal antibodies assisting refolding of firefly luciferase. Protein Sci 13: 1851-1858.
26. Conti E, Franks NP, Brick P (1996) Crystal structure of firefly luciferase throws light on a superfamily of adenylate-forming enzymes. Structure 4: 287-298.
27. Braig K, Otwinowski Z, Hegde R, Boisvert DC, Joachimiak A, et al. (1994) The crystal structure of the bacterial chaperonin GroEL at 2.8 A. Nature 371: 578-586.
28. Zhu X, Zhao X, Burkholder WF, Gragerov A, Ogata CM, et al. (1996) Structural analysis of substrate binding by the molecular chaperone DnaK. Science 272: 1606-1614.
29. Jiang J, Prasad K, Lafer EM, Sousa R (2005) Structural basis of interdomain communication in the Hsc70 chaperone. Mol Cell 20: 513-524.
30. Li J, Qian X, Sha B (2003) The crystal structure of the yeast Hsp40 Ydj1 complexed with its peptide substrate. Structure 11: 1475-1483.
31. Lee S, Sowa ME, Watanabe YH, Sigler PB, Chiu W, et al. (2003) The structure of ClpB: a molecular chaperone that rescues proteins from an aggregated state. Cell 115: 229-240.
32. Harris SF, Shiau AK, Agard DA (2004) The crystal structure of the carboxy-terminal dimerization domain of htpG, the Escherichia coli Hsp90, reveals a potential substrate binding site. Structure 12: 1087-1097.
33. Ali MM, Roe SM, Vaughan CK, Meyer P, Panaretou B, et al. (2006) Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex. Nature 440: 1013-1017.
34. Schwarzman AL, Goldgaber D (1994) Interaction of transthyretin with amyloid β-protein: binding and inhibition of amyloid formation. Ciba Found Symp 199: 146-160.
35. Serag AA, Altenbach C, Gingery M, Hubbell WL, Yeates TO (2002) Arrangement of subunits and ordering of beta-strands in an amyloid sheet. Nat Struct Biol 9: 734-739.
36. Richardson JS, Richardson DC (2002) Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci USA 99: 2754-2759.
37. Fandrich M, Dobson CM (2002) The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J 21: 5682-5690.
38. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95: 13363-13383.
39. Wetzel R, Shivaprasad S, Williams AD (2007) Plasticity of amyloid fibrils. Biochem 46: 1-10.
40. Chen L, Sigler PB (1999) The crystal structure of a GroEL/peptide complex: plasticity as a basis for substrate diversity. Cell 99: 757-768.
41. Ashcroft AE, Brinker A, Coyle JE, Weber F, Kaiser M, et al. (2002) Structural plasticity and noncovalent substrate binding in the GroEL apical domain. A study using electrospay ionization mass spectrometry and fluorescence binding studies. J Biol Chem 277: 33115-33126.
42. Ferguson N, Becker J, Tidow H, Tremmel S, Sharpe TD, et al. (2006) General structural motifs of amyloid protofilaments. Proc Natl Acad Sci USA 103: 16248-16253.
43. Kameda A, Hoshino M, Higurashi T, Takahashi S, Naiki H, et al. (2005) Nuclear magnetic resonance characterization of the refolding intermediate of β2-microglobulin trapped by non-native prolyl peptide bond. J Mol Biol 348: 383-397.
44. Jahn TR, Parker MJ, Homans SW, Radford SE (2006) Amyloid formation under physiological conditions proceeds via a native-like folding intermediate. Nat Struct Mol Biol 13: 195-201.
45. Eakin CM, Berman AJ, Miranker AD (2006) A native to amyloidogenic transition regulated by a backbone trigger. Nat Sruct Mol Biol 13: 202-208.
46. Jahn TR, Radford SE (2005) The yin and yang of protein folding. FEBS J 272: 5962-5970.
47. DebBurman SK, Raymond GJ, Caughey B, Lindquist S (1997) Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci USA 94: 13938-13943.
48. Stockel J, Hartl FU (2001) Chaperonin-mediated de novo generation of prion protein aggregates. J Mol Biol 313: 861-872.
49. Douglas PM, Treusch S, Ren HY, Halfmann R, Duennwald ML, et al. (2008) Chaperone-dependent amyloid assembly protects cells from prion toxicity. Proc Natl Acad Sci U S A 105: 7206-7211.
50. Bush BL, Sheridan RP (1993) PATTY: A Programmable Atom Typer and Language for Automatic Classification of Atoms in Molecular Databases. J Chem Inf Comput Sci 33: 756-762.